BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 12170765)

  • 1. Differential inactivation of caspase-8 in lung cancers.
    Shivapurkar N; Toyooka S; Eby MT; Huang CX; Sathyanarayana UG; Cunningham HT; Reddy JL; Brambilla E; Takahashi T; Minna JD; Chaudhary PM; Gazdar AF
    Cancer Biol Ther; 2002; 1(1):65-9. PubMed ID: 12170765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification.
    Shivapurkar N; Reddy J; Matta H; Sathyanarayana UG; Huang CX; Toyooka S; Minna JD; Chaudhary PM; Gazdar AF
    Oncogene; 2002 Dec; 21(55):8510-4. PubMed ID: 12466971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation profiles of lung tumors.
    Toyooka S; Toyooka KO; Maruyama R; Virmani AK; Girard L; Miyajima K; Harada K; Ariyoshi Y; Takahashi T; Sugio K; Brambilla E; Gilcrease M; Minna JD; Gazdar AF
    Mol Cancer Ther; 2001 Nov; 1(1):61-7. PubMed ID: 12467239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is caspase-8 a neuroendocrine lung tumor suppressor?
    Mazumder S; Almasan A
    Cancer Biol Ther; 2002; 1(1):70-1. PubMed ID: 12197486
    [No Abstract]   [Full Text] [Related]  

  • 5. Epigenetic inactivation of laminin-5-encoding genes in lung cancers.
    Sathyanarayana UG; Toyooka S; Padar A; Takahashi T; Brambilla E; Minna JD; Gazdar AF
    Clin Cancer Res; 2003 Jul; 9(7):2665-72. PubMed ID: 12855645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
    Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF
    Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines.
    Harada K; Toyooka S; Shivapurkar N; Maitra A; Reddy JL; Matta H; Miyajima K; Timmons CF; Tomlinson GE; Mastrangelo D; Hay RJ; Chaudhary PM; Gazdar AF
    Cancer Res; 2002 Oct; 62(20):5897-901. PubMed ID: 12384554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.
    Toyooka KO; Toyooka S; Virmani AK; Sathyanarayana UG; Euhus DM; Gilcrease M; Minna JD; Gazdar AF
    Cancer Res; 2001 Jun; 61(11):4556-60. PubMed ID: 11389090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours.
    Agathanggelou A; Honorio S; Macartney DP; Martinez A; Dallol A; Rader J; Fullwood P; Chauhan A; Walker R; Shaw JA; Hosoe S; Lerman MI; Minna JD; Maher ER; Latif F
    Oncogene; 2001 Mar; 20(12):1509-18. PubMed ID: 11313894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The small GTPase RhoA has greater expression in small cell lung carcinoma than in non-small cell lung carcinoma and contributes to their unique morphologies.
    Varker KA; Phelps SH; King MM; Williams CL
    Int J Oncol; 2003 Mar; 22(3):671-81. PubMed ID: 12579323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression in human lung cancer cell lines of genes of prohormone processing and the neuroendocrine phenotype.
    Vos MD; Scott FM; Iwai N; Treston AM
    J Cell Biochem Suppl; 1996; 24():257-68. PubMed ID: 8806108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.
    Virmani AK; Rathi A; Zöchbauer-Müller S; Sacchi N; Fukuyama Y; Bryant D; Maitra A; Heda S; Fong KM; Thunnissen F; Minna JD; Gazdar AF
    J Natl Cancer Inst; 2000 Aug; 92(16):1303-7. PubMed ID: 10944551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
    Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
    Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer.
    Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Williams NN; Kaiser LR; Croce CM
    Cancer Res; 2003 Jun; 63(12):3352-5. PubMed ID: 12810670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer.
    Wu W; Kemp BL; Proctor ML; Gazdar AF; Minna JD; Hong WK; Mao L
    Cancer Res; 1999 Apr; 59(8):1846-51. PubMed ID: 10213490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines.
    Kelley MJ; Nakagawa K; Steinberg SM; Mulshine JL; Kamb A; Johnson BE
    J Natl Cancer Inst; 1995 May; 87(10):756-61. PubMed ID: 7563154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer.
    Virmani A; Rathi A; Sugio K; Sathyanarayana UG; Toyooka S; Kischel FC; Tonk V; Padar A; Takahashi T; Roth JA; Euhus DM; Minna JD; Gazdar AF
    Int J Cancer; 2003 Aug; 106(2):198-204. PubMed ID: 12800194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
    Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
    Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics of small cell lung carcinoma.
    Wistuba II; Gazdar AF; Minna JD
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation.
    Hopkins-Donaldson S; Ziegler A; Kurtz S; Bigosch C; Kandioler D; Ludwig C; Zangemeister-Wittke U; Stahel R
    Cell Death Differ; 2003 Mar; 10(3):356-64. PubMed ID: 12700635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.